2018 and Beyond: Latvia Pharmaceutical and Healthcare Market Trends and Outlook Study to 2025
Spending on medicines and healthcare in Latvia witnessed steady growth in 2017, reflecting strong potential for new medicine development, infrastructure building and new entry/ expansion opportunities. Both Pharmaceutical sales and consumption are on rise and the outlook to 2025 remains robust driven by strong pharmaceutical market fundamentals.
The goal of this report is to provide complete strategic analysis and forecast the pharmaceutical industry segments over the near to long term future.
This report focuses its attention on pharmaceutical market in Latvia and presents market trends, drivers and challenges facing the R&D professionals, investors, manufacturers, strategists, regulatory and other players. It also presents the pharmaceutical sales of prescription medicines and generic drugs. Further, pharmaceutical imports and exports data is also provided for the country.
The research study on Latvia healthcare spending provides outlook of total spending, government expenditure, private expenditure to 2025. Further, the level of out-of-pocket costs borne by patients is also analyzed.
It additionally explores the level and growth of expenditure on healthcare, new drugs and ongoing research studies. The report also considers the Latvia healthcare industry prospects and infrastructure detailing hospitals, physicians, bed count, and other facilities. The report also analyzes the disease epidemiology trends through details of leading causes of death.
Through transparent and consistent methodology, the research work provides meaningful evidence based insights into the industry. Further, objective measures are presented in ready to use format, which enables ease of understanding of Latvia pharmaceutical market insights and outlook.
The goal of this report is to provide complete strategic analysis and forecast the pharmaceutical industry segments over the near to long term future.
This report focuses its attention on pharmaceutical market in Latvia and presents market trends, drivers and challenges facing the R&D professionals, investors, manufacturers, strategists, regulatory and other players. It also presents the pharmaceutical sales of prescription medicines and generic drugs. Further, pharmaceutical imports and exports data is also provided for the country.
The research study on Latvia healthcare spending provides outlook of total spending, government expenditure, private expenditure to 2025. Further, the level of out-of-pocket costs borne by patients is also analyzed.
It additionally explores the level and growth of expenditure on healthcare, new drugs and ongoing research studies. The report also considers the Latvia healthcare industry prospects and infrastructure detailing hospitals, physicians, bed count, and other facilities. The report also analyzes the disease epidemiology trends through details of leading causes of death.
Through transparent and consistent methodology, the research work provides meaningful evidence based insights into the industry. Further, objective measures are presented in ready to use format, which enables ease of understanding of Latvia pharmaceutical market insights and outlook.
1 TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 EXECUTIVE SUMMARY
2.1 Latvia Pharmaceutical and Healthcare Industry Snapshot
2.2 Latvia Pharmaceuticals Market Overview
3 LATVIA PHARMACEUTICAL MARKET STRATEGIC ANALYSIS REVIEW
3.1 Pharmaceutical Trends in Latvia
3.2 Drivers and Restraints
3.2.1 Market Drivers in Latvia Pharmaceuticals and Healthcare Industry
3.2.2 Drivers Explained
3.2.3 Market Restraints in Latvia Pharmaceuticals and Healthcare Industry
3.2.4 Restraints Explained
4 LATVIA PHARMACEUTICAL MARKET OUTLOOK
4.1 Latvia Pharmaceutical Sales, $ Million, 2015- 2025
4.2 Latvia Pharmaceutical Exports, $ million, 2015- 2025
4.3 Latvia Pharmaceutical Imports, $ Million, 2015- 2025
4.4 Latvia (% contribution) to Regional Pharmaceutical Market size, 2017
4.5 Latvia (% contribution) to Global Pharmaceutical Market size, 2017
4.6 Latvia Prescription Drug Sales, $ Million, 2015- 2025
4.7 Latvia Generic Drug Sales, $ Million, 2015- 2025
5 LATVIA HEALTHCARE MARKET OUTLOOK
5.1 Latvia Healthcare Expenditure Outlook, 2015- 2025
5.2 Latvia Healthcare Expenditure (% of GDP), 2015- 2025
5.3 Latvia Government Healthcare Expenditure (% of total expenditure), 2015- 2025
5.4 Latvia Private Healthcare Expenditure (% of total expenditure), 2015- 2025
5.5 Out of pocket expenditure (% of total expenditure) in Latvia, 2015- 2025
6 LATVIA HEALTHCARE MARKET STATISTICS
6.1 Latvia Mortality by Disease Category, 2017
6.2 Number of Hospitals in Latvia, 2007- 2017
6.3 Number of Hospital Beds in Latvia, 2007- 2017
6.4 Physicians Count in Latvia, 2007- 2017
6.5 Pharmacists Count in Latvia, 2007- 2017
7 LATVIA CLINICAL TRIALS RESEARCH INDUSTRY
7.1 Total Ongoing Clinical Trials in Latvia, 2017
7.2 Ongoing Clinical Trials by Disease Category in Latvia, 2017
7.3 Ongoing Clinical Trials by Type, 2017
7.4 Ongoing Clinical Trials by Status, 2017
7.5 Ongoing Clinical Trials by Sponsor Type, 2017
8 LATVIA DEMOGRAPHIC AND MACROECONOMIC PROFILE
8.1 Latvia Population Forecast by Age Group, 2005- 2025
8.2 Latvia Population Forecast by Location, 2005- 2025
8.3 Latvia GDP Forecast, 2005- 2025
8.4 Latvia GDP Per Capita Forecast, 2005- 2025
8.5 Latvia Disposable Income Forecast, 2005- 2025
9 BUSINESS PROFILES OF LEADING PHARMACEUTICAL COMPANIES
9.1 Johnson and Johnson Pharmaceutical Company Profile
9.2 Bayer Pharmaceutical Company Profile
9.3 Novartis Pharmaceutical Company Profile
9.4 Pfizer Pharmaceutical Company Profile
9.5 Roche Pharmaceutical Company Profile
9.6 Sanofi Pharmaceutical Company Profile
9.7 Merck Pharmaceutical Company Profile
9.8 Gilead Sciences Pharmaceutical Company Profile
9.9 GlaxoSmithKline Pharmaceutical Company Profile
9.10. AstraZeneca Pharmaceutical Company Profile
10 RECENT INDUSTRY DEVELOPMENTS IN LATVIA PHARMACEUTICALS AND HEALTHCARE MARKETS
11 APPENDIX
11.1 About VPA Research
11.2 Sources and Methodology
1.1 List of Tables
1.2 List of Figures
2 EXECUTIVE SUMMARY
2.1 Latvia Pharmaceutical and Healthcare Industry Snapshot
2.2 Latvia Pharmaceuticals Market Overview
3 LATVIA PHARMACEUTICAL MARKET STRATEGIC ANALYSIS REVIEW
3.1 Pharmaceutical Trends in Latvia
3.2 Drivers and Restraints
3.2.1 Market Drivers in Latvia Pharmaceuticals and Healthcare Industry
3.2.2 Drivers Explained
3.2.3 Market Restraints in Latvia Pharmaceuticals and Healthcare Industry
3.2.4 Restraints Explained
4 LATVIA PHARMACEUTICAL MARKET OUTLOOK
4.1 Latvia Pharmaceutical Sales, $ Million, 2015- 2025
4.2 Latvia Pharmaceutical Exports, $ million, 2015- 2025
4.3 Latvia Pharmaceutical Imports, $ Million, 2015- 2025
4.4 Latvia (% contribution) to Regional Pharmaceutical Market size, 2017
4.5 Latvia (% contribution) to Global Pharmaceutical Market size, 2017
4.6 Latvia Prescription Drug Sales, $ Million, 2015- 2025
4.7 Latvia Generic Drug Sales, $ Million, 2015- 2025
5 LATVIA HEALTHCARE MARKET OUTLOOK
5.1 Latvia Healthcare Expenditure Outlook, 2015- 2025
5.2 Latvia Healthcare Expenditure (% of GDP), 2015- 2025
5.3 Latvia Government Healthcare Expenditure (% of total expenditure), 2015- 2025
5.4 Latvia Private Healthcare Expenditure (% of total expenditure), 2015- 2025
5.5 Out of pocket expenditure (% of total expenditure) in Latvia, 2015- 2025
6 LATVIA HEALTHCARE MARKET STATISTICS
6.1 Latvia Mortality by Disease Category, 2017
6.2 Number of Hospitals in Latvia, 2007- 2017
6.3 Number of Hospital Beds in Latvia, 2007- 2017
6.4 Physicians Count in Latvia, 2007- 2017
6.5 Pharmacists Count in Latvia, 2007- 2017
7 LATVIA CLINICAL TRIALS RESEARCH INDUSTRY
7.1 Total Ongoing Clinical Trials in Latvia, 2017
7.2 Ongoing Clinical Trials by Disease Category in Latvia, 2017
7.3 Ongoing Clinical Trials by Type, 2017
7.4 Ongoing Clinical Trials by Status, 2017
7.5 Ongoing Clinical Trials by Sponsor Type, 2017
8 LATVIA DEMOGRAPHIC AND MACROECONOMIC PROFILE
8.1 Latvia Population Forecast by Age Group, 2005- 2025
8.2 Latvia Population Forecast by Location, 2005- 2025
8.3 Latvia GDP Forecast, 2005- 2025
8.4 Latvia GDP Per Capita Forecast, 2005- 2025
8.5 Latvia Disposable Income Forecast, 2005- 2025
9 BUSINESS PROFILES OF LEADING PHARMACEUTICAL COMPANIES
9.1 Johnson and Johnson Pharmaceutical Company Profile
9.2 Bayer Pharmaceutical Company Profile
9.3 Novartis Pharmaceutical Company Profile
9.4 Pfizer Pharmaceutical Company Profile
9.5 Roche Pharmaceutical Company Profile
9.6 Sanofi Pharmaceutical Company Profile
9.7 Merck Pharmaceutical Company Profile
9.8 Gilead Sciences Pharmaceutical Company Profile
9.9 GlaxoSmithKline Pharmaceutical Company Profile
9.10. AstraZeneca Pharmaceutical Company Profile
10 RECENT INDUSTRY DEVELOPMENTS IN LATVIA PHARMACEUTICALS AND HEALTHCARE MARKETS
11 APPENDIX
11.1 About VPA Research
11.2 Sources and Methodology
